Cytodyn Inc (CYDY)

[Monroe1]

If granted, leronlimab would be the first drug authorized to treat mild-to-moderate COVID-19 patients and only the second COVID-19 treatment authorized overall. Gilead Sciences’ remdesivir is currently the only authorized COVID-19 treatment, but it is only authorized for patients with low blood oxygen levels or needing oxygen therapy or more intensive-breathing support (DID, May 4).



From today's release. "Specifically, based on a potential safety signal and an unfavorable risk/benefit profile at this time, the IDMC recommends further enrollment of patients requiring high-flow oxygen or mechanical ventilation be placed on hold pending collection and analysis of further data on patients already enrolled."

Shorts here is you opportunity. Put on a spread. Short Gilead and go long CytoDyn.